NCT 05346484 Brief Summary This is an open-label, dose-escalation, multi-center phase I…
Read more arrow_forwardNCT 05279300 Brief Summary This is a first-in-human (FIH) study to evaluate…
Read more arrow_forwardNCT 05410145 Brief Summary This is a first-in-human (FIH), multicenter, open-label, dose-escalation,…
Read more arrow_forwardNCT 06007482 Brief Summary The goal of this clinical trial is…
Read more arrow_forwardNCT 05985083 Brief Summary This is a first-in-human (FIH), open-label, multi-center, phase…
Read more arrow_forwardNCT 05384626 Brief Summary Phase 1/2, dose escalation and expansion study designed…
Read more arrow_forwardNCT 03899792 Brief Summary This is an open-label, multi-center Phase 1/2 study…
Read more arrow_forwardNCT 06560645 Brief Summary This is a Phase 1 study to determine…
Read more arrow_forwardNCT 03157128 Brief Summary This is an open-label, first-in-human study designed to…
Read more arrow_forwardNCT 06063681 Brief Summary This is an open-label, dose-escalation, multi-center phase 1…
Read more arrow_forward